This Thursday, June 30, at 3:00 pm PST. join us for a live discussion with mental and emotional health expert Linda M. Rio, M.A., LMFT. You can find more information on Live Talk, and a link to the studio here. Join us and participate!

 Listen to our past sessions on demand

News In Brief

LIVE TALK sessions are now available on Demand.  Click here to listen to past shows.

From Recordati Rare Diseases Phase III study confirms the efficacy and safety of   ISTURISA®.  achieving sustained cortisol control in the majority of patients. Read more

Good news from Amryt Pharma for acromegaly patients in Europe.  Read the release from Amryt Pharma on Mycapssa® here.

Corcept Therapeutics announces new communication materials for Phase 3 Trial of Relacolirant in patients with Cushing’s syndrome.  Click here to learn more and see if you qualify. 

Crinetics Pharmaceuticals moves forward with Paltusotine® phase 3 study.  To learn more about the trial and see if you qualify Read more here

Read more about clinical trials from  Xeris Pharma, Camurus AB, and  Ionis Ph

The Podcast

Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.

Semantics, or by definition, the way we relate to different meanings of words or other symbols, are essential. The words we use to communicate and inform are critical. In our session today, we discuss the semantics of pituitary medicine and underline the importance of describing things accurately.

In this podcast,  we dive into the world of endocrine nursing with Dr. Chris Yedinak from the Oregon Health and Science University. For the last five years, she has specialized in neuroendocrine testing and pre-and post-operative care of patients with neuroendocrine and pituitary diseases.  Nurses play a critical role in the care of patients with pituitary disease and we are delighted to bring you this wonderful conversation.